ACT-HIB Injection 10mcg/0.5ml

About ACT-HIB Injection 10mcg/0.5ml

ACT-HIB Injection 10mcg/0.5ml Uses

• Routine childhood immunization against Haemophilus influenzae type b (Hib)
• Prevents Hib related meningitis in infants and young children
• Prevents Hib related pneumonia, epiglottitis and bloodstream infection
• Given as part of the primary vaccination series recommended for children under five years

ACT-HIB Injection 10mcg/0.5ml Benefits

• Builds strong, long lasting immunity against a leading cause of childhood bacterial meningitis
• Reduces the risk of severe Hib complications that need hospitalization
• Backed by decades of global use in national immunization programs
• Well tolerated when given by a trained healthcare provider

What Experts Say

ACT-HIB contains purified capsular polysaccharide from Haemophilus influenzae type b, chemically linked to a tetanus toxoid protein carrier. This conjugation allows a young immune system, which normally responds poorly to plain polysaccharide antigens on their own, to mount a strong and lasting antibody response instead.

Because infant immune systems recognize protein antigens far more effectively than sugar based ones, the tetanus toxoid conjugate helps the body generate memory immune cells alongside antibodies. This is why the vaccine is given as a multi dose primary series in early infancy rather than as a single injection.

Vaccine pharmacology data show that completing the full recommended dose schedule is what produces durable protection, since a partial series leaves antibody levels too low for reliable long term immunity. This is why healthcare providers stress finishing every scheduled dose on time and record each dose carefully.

Drug Class

• Bacterial polysaccharide-protein conjugate vaccine
• Pediatric immunization biological

ACT-HIB Injection 10mcg/0.5ml formula

Available forms

• Injection

How to use ACT-HIB Injection 10mcg/0.5ml?

• Administered only by a doctor, nurse or trained healthcare professional in a clinic or hospital setting
• Given as an intramuscular injection, usually in the thigh for infants or upper arm for older children
• Follows the routine immunization schedule recommended by your child's pediatrician
• Never self-administered or given at home
• The vial must be reconstituted and handled only by trained staff following cold chain protocols

Drug Interactions

• Other Childhood Vaccines: Can usually be given at the same visit as other routine vaccines at separate injection sites
• Immunosuppressive Therapy: Reduced immune response is possible in children on high dose steroids or immunosuppressive drugs
• Blood Products or Immunoglobulins: Recent administration may affect the immune response and timing should be discussed with the doctor
• Other Vaccines Timing: Spacing between doses of different vaccines follows the standard immunization schedule set by the treating pediatrician

Risks and warnings

• Fever: Mild fever is common in the 24 to 48 hours after the injection
• Injection Site Reaction: Redness, swelling or tenderness can occur at the injection site
• Allergy History: Should not be given to a child with a known severe allergy to any vaccine component, including tetanus toxoid
• Illness at Time of Dose: Moderate to severe illness with fever usually means postponing the dose until recovery
• Immunocompromised Children: Discuss timing with the doctor if the child has an immune condition or is on immunosuppressive treatment

ACT-HIB Injection 10mcg/0.5ml Side Effects

• Mild fever
• Injection site redness
• Injection site swelling
• Irritability
• Loss of appetite
• Drowsiness
• Crying more than usual
• Mild swelling of the limb used for injection

Storage Conditions

• Store and transport at 2°C to 8°C in a refrigerator; do not freeze
• Keep the vial in its original carton away from light
• Must remain within cold chain from manufacture until the point of use in a clinic
• Never store at home; this vaccine is stocked and handled only by healthcare facilities